Extended the time limit for presenting various employment tribunal complaints from three months to six months, effective for incidents occurring on or after 1 October 2026.

These Regulations extend the statutory time limits for bringing various employment-related claims before an Employment Tribunal from three months to six months.

The instrument amends specific regulations concerning part-time workers, fixed-term employees, information and consultation rights, blacklisting protection, zero-hours contract exclusivity, and whistleblowing protections in NHS recruitment.

These changes apply to specific acts, failures to act, or the last in a series of such events occurring on or after 1 October 2026 in England, Wales, and Scotland.

Added meningitis, tetanus, diphtheria, and polio vaccines to the list of medicines subject to zero or nominal NHS reimbursement in England starting 20 July 2026.

These regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 to include several additional vaccines in the list of medicines eligible for zero or nominal reimbursement.

They apply to NHS pharmaceutical service providers in England who administer centrally purchased vaccines for meningococcal disease (groups A, C, W, Y, and B), tetanus, diphtheria, and polio.

The instrument ensures that where the government has already paid for the supply of these vaccines, pharmacies do not receive a standard purchase price reimbursement for them.

Established mandatory chemical purity standards and identification criteria for magnesium L-threonate monohydrate used in food supplements in England.

These Regulations establish the statutory purity criteria for magnesium L-threonate monohydrate when used as a mineral source in food supplements.

The Secretary of State for Health and Social Care mandates that this substance must meet specific chemical identities, assay percentages for magnesium and L-threonate, and maximum limits for impurities like arsenic, lead, and oxalic acid.

These requirements apply to any person or business producing or marketing this substance for food supplement use within England.

Corrected a cross-reference error in regulation 13 of the NHS dental services amendment regulations.

This correction slip amends a typographical error found in the National Health Service (Primary Dental Services and Dental Charges) (Amendment) (No. 2) Regulations 2026.

It specifically instructs that the reference to '17A(7)(d)(ii)' in regulation 13(2)(b) be replaced with '13A(7)(d)(ii)'.

The document applies to the published text of the regulations and ensures the statutory references align with the intended legislative structure for primary dental services in England.

Adjusted the paragraph numbering within regulation 1 of the Housing Health and Safety Rating System (England) (Amendment) Regulations 2026.

This document issues a formal clerical correction to the Housing Health and Safety Rating System (England) (Amendment) Regulations 2026.

It directs that the opening text of regulation 1 be designated as paragraph (1) and requires the re-designation of existing paragraphs (1) and (2) as paragraphs (2) and (3) respectively.

These changes apply to the published version of the statutory instrument under the authority of the Controller of His Majesty’s Stationery Office.

Adjusted the transitional inspection date in the Housing Health and Safety Rating System from 22 June to 23 June 2026 to correct a drafting error.

These Regulations amend the transitional provisions related to housing health and safety inspections in England by changing a reference date.

They ensure that the transitional rules for how dwellings are assessed by local housing authorities align with the commencement date of June 23, 2026.

The instrument applies to the Secretary of State and local authorities responsible for enforcing housing standards under the Housing Act 2004.

The Regulations updated the payment percentages within the statutory scheme governing costs associated with branded health service medicines for periods starting July 2026 and beyond.

These Regulations, made by the Secretary of State for Health and Social Care, amend the Branded Health Service Medicines (Costs) Regulations 2018, which establishes a scheme requiring manufacturers and suppliers of branded medicines for the National Health Service (NHS) to pay amounts based on net sales income; the amendments update specific payment percentages applicable for periods beginning July 1st, 2026, and for subsequent years across England, Wales, Scotland, and Northern Ireland.

The Secretary of State classified specific synthetic opioids and their derivatives as temporary class drugs under the Misuse of Drugs Act 1971, applying UK-wide control measures.

The Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2026 exercises powers under the 1971 Act to designate a list of identified synthetic opioid substances, their isomers, salts, and preparations, as drugs subject to temporary control across England, Wales, Scotland, and Northern Ireland, effective from June 11, 2026, while ensuring existing safe custody and misuse regulations immediately apply to them.